Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 331

1.

A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.

Tison F, Keywood C, Wakefield M, Durif F, Corvol JC, Eggert K, Lew M, Isaacson S, Bezard E, Poli SM, Goetz CG, Trenkwalder C, Rascol O.

Mov Disord. 2016 May 23. doi: 10.1002/mds.26659. [Epub ahead of print] Review.

PMID:
27214664
2.

Mavoglurant in Parkinson's Patients With l-Dopa-Induced Dyskinesias: Two Randomized Phase 2 Studies.

Trenkwalder C, Stocchi F, Poewe W, Dronamraju N, Kenney C, Shah A, von Raison F, Graf A.

Mov Disord. 2016 May 23. doi: 10.1002/mds.26585. [Epub ahead of print]

PMID:
27214258
3.

Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT.

Bauer A, Cassel W, Benes H, Kesper K, Rye D, Sica D, Winkelman JW, Bauer L, Grieger F, Joeres L, Moran K, Schollmayer E, Whitesides J, Carney HC, Walters AS, Oertel W, Trenkwalder C; SP0977 study investigators.

Neurology. 2016 May 10;86(19):1785-93. doi: 10.1212/WNL.0000000000002649. Epub 2016 Apr 13.

4.

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

Mollenhauer B, Zimmermann J, Sixel-Döring F, Focke NK, Wicke T, Ebentheuer J, Schaumburg M, Lang E, Trautmann E, Zetterberg H, Taylor P, Friede T, Trenkwalder C; DeNoPa Study Group.

Neurology. 2016 May 6. pii: 10.1212/WNL.0000000000002651. [Epub ahead of print]

PMID:
27164658
5.

A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia.

Trenkwalder C, Berg D, Rascol O, Eggert K, Ceballos-Baumann A, Corvol JC, Storch A, Zhang L, Azulay JP, Broussolle E, Defebvre L, Geny C, Gostkowski M, Stocchi F, Tranchant C, Derkinderen P, Durif F, Espay AJ, Feigin A, Houeto JL, Schwarz J, Di Paolo T, Feuerbach D, Hockey HU, Jaeger J, Jakab A, Johns D, Linazasoro G, Maruff P, Rozenberg I, Sovago J, Weiss M, Gomez-Mancilla B.

Mov Disord. 2016 Mar 15. doi: 10.1002/mds.26569. [Epub ahead of print]

PMID:
26990766
6.

Restless legs syndrome associated with major diseases: A systematic review and new concept.

Trenkwalder C, Allen R, Högl B, Paulus W, Winkelmann J.

Neurology. 2016 Apr 5;86(14):1336-43. doi: 10.1212/WNL.0000000000002542. Epub 2016 Mar 4. Review.

PMID:
26944272
7.

Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study.

Trenkwalder C, Canelo M, Lang M, Schroeder H, Kelling D, Berkels R, Schollmayer E, Heidbrede T, Benes H.

Sleep Med. 2015 Nov 11. pii: S1389-9457(15)02018-3. doi: 10.1016/j.sleep.2015.10.006. [Epub ahead of print]

PMID:
26896370
8.

Significant association between systolic and diastolic blood pressure elevations and periodic limb movements in patients with idiopathic restless legs syndrome.

Cassel W, Kesper K, Bauer A, Grieger F, Schollmayer E, Joeres L, Trenkwalder C.

Sleep Med. 2016 Jan;17:109-20. doi: 10.1016/j.sleep.2014.12.019. Epub 2015 Feb 23.

PMID:
26847983
9.

Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.

Trenkwalder C, Chaudhuri KR, Martinez-Martin P, Rascol O, Ehret R, Vališ M, Sátori M, Krygowska-Wajs A, Marti MJ, Reimer K, Oksche A, Lomax M, DeCesare J, Hopp M; PANDA study group.

Lancet Neurol. 2015 Dec;14(12):1161-70. doi: 10.1016/S1474-4422(15)00243-4. Epub 2015 Oct 19.

PMID:
26494524
10.

Restless legs syndrome-current therapies and management of augmentation.

Trenkwalder C, Winkelmann J, Inoue Y, Paulus W.

Nat Rev Neurol. 2015 Aug;11(8):434-45. doi: 10.1038/nrneurol.2015.122. Epub 2015 Jul 28. Review.

PMID:
26215616
11.

Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations.

Trenkwalder C, Chaudhuri KR, García Ruiz PJ, LeWitt P, Katzenschlager R, Sixel-Döring F, Henriksen T, Sesar Á, Poewe W; Expert Consensus Group for Use of Apomorphine in Parkinson's Disease, Baker M, Ceballos-Baumann A, Deuschl G, Drapier S, Ebersbach G, Evans A, Fernandez H, Isaacson S, van Laar T, Lees A, Lewis S, Martínez Castrillo JC, Martinez-Martin P, Odin P, O'Sullivan J, Tagaris G, Wenzel K.

Parkinsonism Relat Disord. 2015 Sep;21(9):1023-30. doi: 10.1016/j.parkreldis.2015.06.012. Epub 2015 Jun 17. Review.

PMID:
26189414
12.

Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy.

Doppler K, Weis J, Karl K, Ebert S, Ebentheuer J, Trenkwalder C, Klebe S, Volkmann J, Sommer C.

Mov Disord. 2015 Oct;30(12):1688-92. doi: 10.1002/mds.26293. Epub 2015 Jul 14.

PMID:
26175301
13.

King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.

Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P; EUROPAR and the IPMDS Non Motor PD Study Group.

Mov Disord. 2015 Oct;30(12):1623-31. doi: 10.1002/mds.26270. Epub 2015 Jun 11.

PMID:
26096067
14.

REM sleep-associated motor behaviors in Parkinson's disease patients with heterozygous Parkin mutations.

Sixel-Döring F, Lohmann K, Klein C, Trenkwalder C, Mollenhauer B.

Mov Disord. 2015 Apr;30(4):597-8. doi: 10.1002/mds.26193. Epub 2015 Mar 15. No abstract available.

PMID:
25771888
15.

REM Sleep Behavioral Events and Dreaming.

Muntean ML, Trenkwalder C, Walters AS, Mollenhauer B, Sixel-Döring F.

J Clin Sleep Med. 2015 Apr 15;11(5):537-41. doi: 10.5664/jcsm.4698.

16.

Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease.

Schulte EC, Fukumori A, Mollenhauer B, Hor H, Arzberger T, Perneczky R, Kurz A, Diehl-Schmid J, Hüll M, Lichtner P, Eckstein G, Zimprich A, Haubenberger D, Pirker W, Brücke T, Bereznai B, Molnar MJ, Lorenzo-Betancor O, Pastor P, Peters A, Gieger C, Estivill X, Meitinger T, Kretzschmar HA, Trenkwalder C, Haass C, Winkelmann J.

Eur J Hum Genet. 2015 Oct;23(10):1328-33. doi: 10.1038/ejhg.2014.300. Epub 2015 Jan 21.

PMID:
25604855
17.

Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation.

Picchietti DL, Hensley JG, Bainbridge JL, Lee KA, Manconi M, McGregor JA, Silver RM, Trenkwalder C, Walters AS; International Restless Legs Syndrome Study Group (IRLSSG).

Sleep Med Rev. 2015 Aug;22:64-77. doi: 10.1016/j.smrv.2014.10.009. Epub 2014 Nov 4. Review.

PMID:
25553600
18.

Diagnostic value of the REM sleep behavior disorder screening questionnaire in Parkinson's disease.

Stiasny-Kolster K, Sixel-Döring F, Trenkwalder C, Heinzel-Gutenbrunner M, Seppi K, Poewe W, Högl B, Frauscher B.

Sleep Med. 2015 Jan;16(1):186-9. doi: 10.1016/j.sleep.2014.08.014. Epub 2014 Nov 13.

PMID:
25534709
19.

High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.

Doss S, Wandinger KP, Hyman BT, Panzer JA, Synofzik M, Dickerson B, Mollenhauer B, Scherzer CR, Ivinson AJ, Finke C, Schöls L, Müller Vom Hagen J, Trenkwalder C, Jahn H, Höltje M, Biswal BB, Harms L, Ruprecht K, Buchert R, Höglinger GU, Oertel WH, Unger MM, Körtvélyessy P, Bittner D, Priller J, Spruth EJ, Paul F, Meisel A, Lynch DR, Dirnagl U, Endres M, Teegen B, Probst C, Komorowski L, Stöcker W, Dalmau J, Prüss H.

Ann Clin Transl Neurol. 2014 Oct;1(10):822-32. doi: 10.1002/acn3.120. Epub 2014 Oct 18.

20.

Evaluation of cutoff scores for the Parkinson's disease sleep scale-2.

Suzuki K, Miyamoto T, Miyamoto M, Suzuki S, Numao A, Watanabe Y, Tatsumoto M, Sakuta H, Watanabe Y, Fujita H, Iwanami M, Sada T, Kadowaki T, Hashimoto K, Trenkwalder C, Hirata K.

Acta Neurol Scand. 2015 Jun;131(6):426-30. doi: 10.1111/ane.12347. Epub 2014 Nov 17.

PMID:
25402773
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk